Affirms strong 2023 individual Medicare Advantage membership growth of at least 625,000, or 13.7% growth over FY22 ending membership; anticipates growth to be meaningfully higher than the industry growth.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HUM:
- Humana’s (HUM) New Defense Contract Extension Could Be Worth $16.26B
- Evolent Health price target raised to $59 from $57 at Cowen
- Early notable gainers among liquid option names on January 19th
- Evolent Health jumps after announcing expansion of Humana pact
- Humana put volume heavy and directionally bearish
